Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 17.44 as of Wednesday, July 29, 2026.
Forward PE Ratio (17.44) = Close Price ($314.23) / Consensus Forward EPS ($18.02)
FORWARD PE RATIO
17.44
SECTOR MEDIAN · HEALTHCARE
18.52
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-5.83%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$25.77B
Forward PE Ratio
17.44
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.77B | 17.44 |
| Incyte Corporation (INCY)vs › | $25.96B | 16.31 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.04B | 20.95 |
| Waters Corporation (WAT)vs › | $25.02B | 26.43 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | 37.06 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.06B | 28.63 |
| BioNTech SE (BNTX)vs › | $23.38B | N/A |
| DexCom, Inc. (DXCM)vs › | $28.88B | 28.29 |
| STERIS plc (STE)vs › | $22.45B | 21.42 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.16B | 13.13 |
Trailing P/E
27.8
reported TTM EPS
Forward P/E
17.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $18.02 implies +59.6% EPS growth vs the reported trailing $11.29.
At today's $314.23 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $18.02 | $17.72 – $18.35 | 10 | 17.4x |
| 2027-12-31 | $19.46 | $18.59 – $19.97 | 12 | 16.1x |
| 2028-12-31 | $21.13 | $19.00 – $23.92 | 8 | 14.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
